Article information
Abstract
As cerebral toxoplasmosis is the most common cerebral focal lesion in AIDS patients, this study evaluated three PCR markers for diagnosis, since some limitations remain present, such as low parasite levels in some clinical samples. The molecular markers were B22-B23 and Tg1-Tg2 (based on the B1 gene) and Tox4-Tox5 (non-coding fragment, repeated 200-300-fold). DNA samples from 102 AIDS patients with previously known diagnosis were analyzed. The cerebral toxoplasmosis group was constituted of DNA extracted from the blood of 66 AIDS patients, which was collected before or until the third day of the therapy for toxoplasmosis. DNA from the blood of 36 AIDS patients with other neurologic opportunistic infections was used as control group. Sensitivities of B22-B23, Tg1-Tg2, and Tox4-Tox5 markers were of 95.5%, 93.9%, and 89.3%, respectively. In the control group, the specificities were of 97.2% (B22-B23), 88.9% (Tg1-Tg2), and 91.7% (Tox4-Tox5). The association of at least two markers increased the PCR sensitivity and specificity. The concordance index between two markers varied from 83.3% to 93.1%. These data demonstrated that all markers evaluated here were highly sensitive for T. gondii determination, although B22-B23 has been shown to be the best. The association of two markers increases PCR sensitivity, but the procedure was more expensive and time-consuming.
Keywords:
AIDS
cerebral toxoplasmosis
molecular diagnosis
PCR markers
Full text is only aviable in PDF
References
[1.]
J.P. Dubey.
Advances in the life cycle of Toxoplasma gondii.
Int J Parasitol, 7 (1998), pp. 1019-1024
[2.]
J.G. Montoya, O. Liesenfeld.
Toxoplasmosis.
Lancet, 363 (2004), pp. 1965-1976
[3.]
D.E. Hill, S. Chirukandoth, J.P. Dubey.
Biology and epidemiology of Toxoplasma gondii in man and animals.
Anim Health Res Rev, 6 (2005), pp. 41-61
[4.]
I.M.R. Ferreira, J.E. Vidal, T.A. Costa-Silva, et al.
Toxoplasma gondii: genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers.
Exp Parasitol, 118 (2008), pp. 221-227
[5.]
A. Elbez-Rubinstein, D. Ajzenberg, M.L. Dardé, et al.
Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review.
J Infect Dis, 199 (2009), pp. 280-285
[6.]
P.D. Glasner, C. Silveira, D. Kruszon-Moran, et al.
An unusually high prevalence of ocular toxoplasmosis in Southern Brazil.
Am J Ophthalmol, 114 (1992), pp. 136-144
[7.]
B. Carme, F. Bissuel, D. Ajzenberg, et al.
Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana.
J Clin Microbiol, 40 (2002), pp. 4037-4044
[8.]
V.L. Pereira-Chioccola, J.E. Vidal, C. Su.
Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients.
Future Microbiol, 4 (2009), pp. 1363-1379
[9.]
A. Antinori, D. Larussa, A. Cingolani, et al.
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Clin Infect Dis, 39 (2004), pp. 1681-1691
[10.]
J.E. Vidal, A.V. Hernandez, A.C. Penalva de Oliveira, et al.
Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era.
AIDS Patient Care STDS, 19 (2005), pp. 840-848
[11.]
S. Bretagne.
Molecular diagnostics in clinical parasitology and mycology: limits of the current polymerase chain reaction (PCR) assays and interest of the real-time PCR assays.
Clin Microbiol Infect, 9 (2003), pp. 505-511
[12.]
J.E. Vidal, F.A. Colombo, A.C. Penalva de Oliveira, et al.
PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients.
J Clin Microbiol, 42 (2004), pp. 4765-4768
[13.]
F.A. Colombo, J.E. Vidal, A.C. Penalva de Oliveira, et al.
Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples.
J Clin Microbiol, 43 (2005), pp. 5044-5047
[14.]
W.L. Homan, M. Vercammenb, J. De Braekeleer, H. Verschueren.
Identification of a 200-to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR.
Inter J Parasitol, 30 (2000), pp. 69-75
[15.]
J.L. Burg, C.M. Grover, P. Pouletty, J.C. Boothroyd.
Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.
J Clin Microbiol, 27 (1989), pp. 1787-1792
[16.]
C.M. Grover, P. Thulliez, J.S. Remington, J.C. Boothroyd.
Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid.
J Clin Microbiol, 28 (1990), pp. 2297-2301
[17.]
J.G. Montoya, S. Parmley, O. Liesenfield, et al.
Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis.
Ophthalmology, 106 (1999), pp. 1554-1563
[18.]
C.D. Jones, N. Okhravi, P. Adamson, et al.
Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of Toxoplasma gondii in aqueous humor.
Invest Ophthalmol Vis Sci, 41 (2000), pp. 634-644
[19.]
A. Calderaro, G. Piccolo, C. Gorrini, et al.
Comparison between two Real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii.
Acta Biomed, 77 (2006), pp. 75-80
[20.]
B. Edvinsson, M. Lappalainen, B. Evengård, ESCMID Study Group for Toxoplasmosis.
Real-time PCR targeting a 529-bp repeat element for diagnosis of toxoplasmosis.
Clin Microbiol Infect, 12 (2006), pp. 131-136
[21.]
T.S. Okay, L. Yamamoto, L.C. Oliveira, et al.
Significant performance variation among PCR systems in diagnosing congenital toxoplasmosis in São Paulo, Brazil: analysis of 467 amniotic fluid samples.
Clinics, 641 (2009), pp. 171-176
[22.]
P. Portegies, L. Solod, P. Cinque, et al.
Guidelines for the diagnosis and management of neurological complications of HIV infection.
Eur J Neurol, 11 (2004), pp. 297-304
[23.]
A. Cingolani, A. De Luca, A. Ammassari, et al.
PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions.
J Med Microbiol, 45 (1996), pp. 472-476
[24.]
R.T. Mesquita, A.P. Ziegler, R.M. Hiramoto, J.E. Vidal, V.L. Pereira-Chioccola.
Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients.
J Med Microbiol, 59 (2010), pp. 641-647
[25.]
S. Jalal, C.E. Nord, M. Lappalainen, B. Evengard.
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR.
Clin Microbiol Infect, 10 (2004), pp. 937-939
[26.]
C.N. Lee, H.M. Cavanagh, S.T. Lo, C.S. Ng.
Human papillomavirus infection in non-neoplastic uterine cervical disease in Hong Kong.
Brit. J. Biomed. Sci., 58 (2001), pp. 85-91
[27.]
E. Chabbert, L. Lachaud, L. Crobu, P. Bastien.
Comparison of two widely used PCR primer systems for detection of Toxoplasma in amniotic fluid, blood and tissues.
J Clin Microbiol, 42 (2004), pp. 1719-1722
[28.]
S. Cassaing, M.H. Bessières, A. Berry, et al.
Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR.
J Clin Microbiol, 44 (2006), pp. 720-724
[29.]
J.M. Costa, C. Pautas, P. Ernault, et al.
Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes.
J Clin Microbiol, 38 (2000), pp. 2929-2932
[30.]
U. Reischl, S. Bretagne, D. Krüger, et al.
Comparison of two DNA targets for the diagnosis of toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes.
BMC Infect Dis, 3 (2003), pp. 7-9
[31.]
W.A. Al-Soud, P. Radstrom.
Capacity of nine thermostable DNA polymerases to mediate DNA amplification in the presence of PCR-inhibiting samples.
Appl Environ Microbiol, 64 (1998), pp. 3748-3753
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
